ACIU

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

AC Immune SA (ACIU) Earnings Date & Reports

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

ACIU is expected to report earnings to rise 24.64% to -20 cents per share on April 28

AC Immune SA ACIU Stock Earnings Reports

Q1'25

Est.

$-0.20

Q4'24

Beat

by $0.02

Q3'24

Beat

by $0.19

Q2'24

Missed

by $0.71

Q1'24

Missed

by $0.08

The last earnings report on March 13 showed earnings per share of -16 cents, beating the estimate of -18 cents. With 112.35K shares outstanding, the current market capitalization sits at 164.67M.

View a ticker or compare two or three

Compare

ACIU

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ACIU
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of therapeutic and diagnostic products to prevent and modify diseases caused by misfolding proteins

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

EPFL Innovation Park

Phone

+41 213459121

Employees

161

Web

https://www.acimmune.com